Actualizado 17/01/2008 02:02 CET
- Comunicado -

New Study Shows Biologic Therapy Enbrel(R) (etanercept) Effective in Treating Psoriasis in Children and Adolescents (y 2

(1) Paller, AS et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008;358:241-51

(2) Christophers E. Psoriasis - Epidemiology and Clinical Spectrum. Clin Exp Dermatol 2001;26:314-320

(3) Gottlieb, A. Psoriasis: Emerging Therapeutic Strategies, Nature Reviews volume 4, January 2005

(4) National Psoriasis Foundation. Medical facts about psoriasis in childhood. 2007. Available at: http://www.psoriasis.org/about/youth/parents/medicalfacts.ph.... (Accessed January 2008)

(5) Mrowietz, U et al The importance of disease associations and concomitant therapy for the long-term management of Psoriasis patients Arch Dermatol Res (2006)

(6) Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401-7

(7) Enbrel EMEA SPC

For further information, please contact: Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct tel: +44(0)1628-692536, Email: markhagl@wyeth.com,; OgilvyHealthPR: Karen Crum, Direct Tel: +44(0)207-108-6411, Email: karen.crum@ohpr.com; Jodi Lewis, Direct Tel: +44(0)207-108-6086, Email: jodi.lewis@ohpr.com

Mejora la comunicación de tu empresa con Europa Press Comunicación